A detailed history of Nicholas Investment Partners, LP transactions in Natera, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 6,468 shares of NTRA stock, worth $944,716. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,468
Previous 6,083 6.33%
Holding current value
$944,716
Previous $658,000 24.92%
% of portfolio
0.09%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$97.75 - $129.67 $37,633 - $49,922
385 Added 6.33%
6,468 $822,000
Q2 2024

Aug 07, 2024

BUY
$85.28 - $112.6 $518,758 - $684,945
6,083 New
6,083 $658,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.